Iht Wealth Management, LLC Ardelyx, Inc. Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$4.23 - $8.29 $80,010 - $156,805	-18,915 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$2.15 - $6.28 $9,991 - $29,183	-4,647 Reduced 19.72%	18,915 $89,000
Q2 2019 Aug 12, 2019	SELL	$2.49 - $3.73 $1,245 - $1,865	-500 Reduced 2.08%	23,562 $63,000
Q1 2019 May 16, 2019	SELL	$1.88 - $3.35 $637 - $1,135	-339 Reduced 1.39%	24,062 $67,000
Q4 2018 Feb 15, 2019	SELL	$1.66 - $4.16 $44,723 - $112,078	-26,942 Reduced 52.47%	24,401 $44,000
Q2 2018 Aug 13, 2018	BUY	$3.7 - $5.8 $189,969 - $297,789	51,343 New	51,343 $190,000

220

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $769M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.